Veterinary Medicines

Nobilis Multriva RT+IBm+ND+Gm+REOm+EDS (--) Emulsion for injection

Authorised
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Ulster, Inactivated
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
  • Infectious bursal disease virus, strain GB02, Inactivated
  • Infectious bursal disease virus, strain 89/03, Inactivated
  • Avian reovirus, strain ARV-1, Inactivated
  • Avian reovirus, strain ARV-4, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis Multriva RT+IBm+ND+Gm+REOm+EDS (--) Emulsion for injection
Active substance:
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Ulster, Inactivated
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
  • Infectious bursal disease virus, strain GB02, Inactivated
  • Infectious bursal disease virus, strain 89/03, Inactivated
  • Avian reovirus, strain ARV-1, Inactivated
  • Avian reovirus, strain ARV-4, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
    Presentation_strength:≥19.0 U Reference:EMEA/V/VAMF/0001 Index:3
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    Presentation_strength:≥ 4.8 log2 HI Reference:EMEA/V/VAMF/0002 Index:4
  • Newcastle disease virus, strain Ulster, Inactivated
    Presentation_strength:≥ 5.9 U Reference:EMEA/V/VAMF/0004 Index:5
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
    Presentation_strength:≥368.3 U Reference:EMEA/V/VAMF/0009 Index:6
  • Infectious bursal disease virus, strain GB02, Inactivated
    Presentation_strength:≥ 100.9 U1 Reference:EMEA/V/VAMF/0005 Index:7
  • Infectious bursal disease virus, strain 89/03, Inactivated
    Presentation_strength:≥ 88.6 U Reference:EMEA/V/VAMF/0006 Index:8
  • Avian reovirus, strain ARV-1, Inactivated
    Presentation_strength:≥ 11.5 U Reference:EMEA/V/VAMF/0007 Index:9
  • Avian reovirus, strain ARV-4, Inactivated
    Presentation_strength:≥ 11.4 U1 Reference:EMEA/V/VAMF/0008 Index:10
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA24
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Bottle (PET), Package_size:1 bottle, Content:600 ml (2000 doses)
  • Packaging:Bottle (PET), Package_size:1 bottle, Content:300 ml (1000 doses)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - known active substance (Article 8 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 17/05/2024
Download
Bulgarian (PDF)
Published on: 17/05/2024
Download
Croatian (PDF)
Published on: 17/05/2024
Download
Czech (PDF)
Published on: 17/05/2024
Download
Danish (PDF)
Published on: 17/05/2024
Download
Dutch (PDF)
Published on: 17/05/2024
Download
Estonian (PDF)
Published on: 17/05/2024
Download
Finnish (PDF)
Published on: 17/05/2024
Download
French (PDF)
Published on: 17/05/2024
Download
German (PDF)
Published on: 17/05/2024
Download
Greek (PDF)
Published on: 17/05/2024
Download
Hungarian (PDF)
Published on: 17/05/2024
Download
Icelandic (PDF)
Published on: 17/05/2024
Download
Italian (PDF)
Published on: 17/05/2024
Download
Latvian (PDF)
Published on: 17/05/2024
Download
Lithuanian (PDF)
Published on: 17/05/2024
Download
Maltese (PDF)
Published on: 17/05/2024
Download
Norwegian (PDF)
Published on: 17/05/2024
Download
Polish (PDF)
Published on: 17/05/2024
Download
Portuguese (PDF)
Published on: 17/05/2024
Download
Romanian (PDF)
Published on: 17/05/2024
Download
Slovak (PDF)
Published on: 17/05/2024
Download
Slovenian (PDF)
Published on: 17/05/2024
Download
Spanish (PDF)
Published on: 17/05/2024
Download
Swedish (PDF)
Published on: 17/05/2024
Download

ema-puar-v5887-nobilismultrivartibmndgmreomeds-en.pdf

English (PDF)
Published on: 28/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."